DNLI

DENALI THERAPEUTICS INC

DNLI·24823R105·US·Common Stock·Healthcare - Biotechnology-13D/G

DNLI (DENALI THERAPEUTICS INC) is held by 138 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($250.3M), BAILLIE GIFFORD & CO ($231.7M), Temasek Holdings (Private) Ltd ($134.6M). Net institutional sentiment: Mixed.

138
Holders
(12 Elite)
$2.3B
Total Value
66% (137)
Consensus
90 buying - 47 selling
13F: Insider & Congress:
DNLISmart Money Verdict
View all
Held by 138 funds
12 elite
Who's Trading
ActivistTRT. Rowe Price Investment Management, Inc.10.2%Jul 8, 2026
ActivistTRT. Rowe Price Investment Management, Inc.5.4%May 15, 2026
ActivistFMR LLCFMR LLC4.2%May 6, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
InsiderWJWatts Ryan J.Sell $581KJan 6, 2026
InsiderSOSchuth Alexander O.Sell $284KJan 6, 2026
InsiderHCHo CaroleSell $12KAug 13, 2025
InsiderSOSchuth Alexander O.Sell $40KAug 12, 2025
InsiderHCHo CaroleSell $40KAug 12, 2025
ActivistWellington Management Group LLPWellington Management Group LLP3.9%Aug 12, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
13M(+2.5%)$250.3M0.0%+28.36%
32
Decreased
12.1M(-2.0%)$231.7M0.2%-30.62%
0
Unchanged
7M$134.6M0.4%+10.13%
0
Increased
6.3M(+0.1%)$120.4M0.0%+31.28%
30
New
6.1M$118M0.0%+28.27%
42
New
6.1M$117.5M0.0%+28.27%
42
Decreased
4.6M(-25.0%)$87.8M0.0%+27.52%
0
Decreased
4.4M(-11.1%)$85.1M0.0%+19.16%
0
Increased
4.4M(+14.9%)$84.6M0.0%+48.09%
34
Unchanged
3.7M$71.6M0.4%+8.89%
0
Increased
3.7M(+7.8%)$71.6M0.0%-7.88%
32
Increased
3.2M(+1.4%)$61.4M0.1%+76.49%
36
Increased
2.7M(+13.4%)$51.7M0.0%+25.32%
33
Increased
2.6M(+6.9%)$49.4M0.0%+50.36%
31
Increased
2.6M(+92.5%)$48.4M0.1%+43.84%
46
Decreased
2.5M(-32.6%)$48.3M0.0%+5.67%
0
Decreased
2.9M(-18.7%)$47.8M0.0%+5.57%
0
Decreased
2.5M(-37.1%)$47.3M0.0%+27.90%
0
Decreased
2.4M(-5.9%)$46.8M0.0%+48.35%
0
Increased
1.9M(+126.0%)$37.3M0.1%+39.40%
56

Showing 1-20 of 149

1 / 8

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used